Gufic Biosciences

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue215.20202.20195.87204.06204.29
Expenses184.26172.64168.76175.96175.03
EBITDA39.7136.8835.1137.0438.74
EBIT35.4132.7430.7732.7334.44
Profit Before Tax30.9529.5627.1228.1129.27
Net Profit23.2122.2620.0520.8621.78
Financial Ratios
Operating Profit Margin18.48%18.28%18.01%18.26%18.97%
Net Profit Margin10.80%11.03%10.28%10.29%10.67%
Earning Per Share (Diluted)2.392.232.002.082.17
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ